Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoski

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|March 26, 1998
Aminopyrimidines with high affinity for both serotonin and dopamine receptorsD Wustrow, T Belliotti, S Glase, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Journal of Medicinal Chemistry|June 23, 2006
3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonistsMichael J Konkel, Bharat Lagu, Lakmal W Boteju, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonistsAmy B Dounay, Nancy S Barta, Brian M Campbell, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Pyrazolo[1,5-a]pyrimidine CRF-1 receptor antagonistsD J Wustrow, T Capiris, R Rubin, et al.
Pharmacology, Biochemistry, and Behavior|February 26, 1998
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonistA E Corbin, T A Pugsley, H C Akunne, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Isoindolinone enantiomers having affinity for the dopamine D4 receptorT R Belliotti, W A Brink, S R Kesten, et al.
Journal of Medicinal Chemistry|December 22, 1999
A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agentT R Belliotti, D J Wustrow, W A Brink, et al.
Journal of Medicinal Chemistry|March 26, 1998
Aminopyrimidines with high affinity for both serotonin and dopamine receptorsD Wustrow, T Belliotti, S Glase, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D(2)/D(3) partial agonist and 5-HT(1A) agonist actions. I. Neurochemical effectsH C Akunne, K T Zoski, M D Davis, et al.
Journal of Medicinal Chemistry|June 23, 2006
3-arylimino-2-indolones are potent and selective galanin GAL3 receptor antagonistsMichael J Konkel, Bharat Lagu, Lakmal W Boteju, et al.
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonistsAmy B Dounay, Nancy S Barta, Brian M Campbell, et al.
Pageof 3